Self-Assembled Multivalent Aptamer Nanoparticles with Potential CAR-like Characteristics Could Activate T Cells and Inhibit Melanoma Growth-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Self-Assembled Multivalent Aptamer Nanoparticles with Potential CAR-like Characteristics Could Activate T Cells and Inhibit Melanoma Growth

Published:2020-06 Issue: Volume:17 Page:9-20
ISSN:2372-7705
Container-title:Molecular Therapy - Oncolytics
language:en
Short-container-title:Molecular Therapy - Oncolytics

Author:

Bai Chenjun,Gao Shanshan,Hu Sai,Liu Xuemei,Li Hui,Dong Jie,Huang Aixue,Zhu Lingling,Zhou Pingkun,Li Shaohua,Shao Ningsheng

Funder

Key R&D of the Ministry of Science and Technology of China

Publisher

Elsevier BV

Subject

Pharmacology (medical),Cancer Research,Oncology,Molecular Medicine

Reference48 articles.

1. Novel cancer immunotherapy agents with survival benefit: recent successes and next steps;Sharma;Nat. Rev. Cancer,2011

2. Molecular mechanisms of T cell co-stimulation and co-inhibition;Chen;Nat. Rev. Immunol.,2013

3. Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential;Sharma;Cell,2015

4. Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19;Kochenderfer;Blood,2010

5. Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia;Porter;N. Engl. J. Med.,2011

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Future embracing: exosomes driving a revolutionary approach to the diagnosis and treatment of idiopathic membranous nephropathy;Journal of Nanobiotechnology;2024-08-08

2. RNA nanostructures for targeted drug delivery and imaging;RNA Biology;2024-03-31

3. Aptamers as an approach to targeted cancer therapy;Cancer Cell International;2024-03-16

4. Functional Nucleic Acid-Based Immunomodulation for T Cell-Mediated Cancer Therapy;ACS Nano;2023-12-20

5. Moving towards Personalized Medicine—The Broad Use of Aptamers for Targeted Theranostic;Applied Sciences;2023-10-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3